Skip to main content
Menu
Our research
Breast Cancer
Gastrointestinal Cancers
Prostate Cancer
Uncommon Cancers
Novel Cancer Therapeutics
Targeted Physical Therapies
Digital - Capability, Informatics, Big Data, e-Health
Genotypes, Phenotypes and Cancer Evolution
About us
Our facilities
Working with us
Our collaborations
Acknowledging the NIHR BRC
Open Access policy
Staff profiles
Patient and public involvement and engagement
What is patient and public involvement and engagement at the BRC?
Getting involved: for patients and the public
Involving patients and the public: for researchers
Patient and public engagement events
BRC patient representatives: our experiences
Patient and public involvement and engagement: training resources
News & events
BRC Training Hub
BRC training opportunities
In profile: early career researchers
Fellowship funding
Training courses and events
Support for clinical researchers
Support for nurse, AHP & pharmacy researchers
Research support staff
Our partnerships
Training and education resources
COVID-19 resources
Advance magazine
Video library
Big Data: a guide for patients and the public
Patient and Public Involvement: Experience, Impact and Benefits
Patient and Public Involvement: The Importance of Diversity
What does the future hold for breast cancer? Session One
What does the future hold for breast cancer? Session Two
Search
Search
Back to main site
Advance
The magazine for the UK's only Biomedical Research Centre dedicated to cancer
Browse by topic
Drug development
Gene testing
Radiotherapy
Clinical trials
TYPE: NEWS
Forefront
Patient and public involvement
Case study
Expert voice
In profile
Q&A
Social
In numbers
News
News
To be precise
News
Drug targets stomach cancer gene 'addiction'
News
NIHR funding for Clinical Research Facility
News
Johann de Bono is Regius Professor
News
New genetic test for children with cancer
